Analysis of appropriateness and safety when discharging patients on triple-antithrombotic therapies.

Taylor RobichauxKristyn EdwardsAshley CarterAndrea WashingtonShelby Brooks

Published in: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists (2024)

In this single-center study, triple-antithrombotic therapy appropriately adhered to the 2020 ACC consensus statement for one-third of patients discharged on this therapy.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
atrial fibrillation
stem cells
mesenchymal stem cells